Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...
including lung cancer. The combination craze In fact, the immunotherapy field has seen some of the most frenzied licensing and partnering of any therapy area in 2014. The message this year has ...
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
Terrence Wise’s medical mistreatment at the notorious federal lockup reduced his chance of surviving past five years to about ...
With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...
BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...
6 天
News Medical on MSNResearchers develop model to identify tumor-fighting immune cells in lung cancer patientsResearchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...
Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...
Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...
Kolkata: Cancer care is set to take a leap forward across multiple city hospitals that are enhancing oncology units even as ...
5 天
GlobalData on MSNAstraZeneca lung cancer therapy Imfinzi recommended for EU approvalThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended AstraZeneca's Imfinzi ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果